Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro

Abstract Activation-induced cytidine deaminase (AID) is known for its established role in antibody production. AID induces the diversification of antibodies by deaminating deoxycytidine (C) within immunoglobulin genes. The capacity of AID to deaminate 5-methyldeoxycytidine (5 mC) and/or 5-hydroxymet...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lucyna Budzko, Paulina Jackowiak, Karol Kamel, Joanna Sarzynska, Janusz M. Bujnicki, Marek Figlerowicz
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8ffed197854841b4b662d412e8d4c692
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ffed197854841b4b662d412e8d4c692
record_format dspace
spelling oai:doaj.org-article:8ffed197854841b4b662d412e8d4c6922021-12-02T16:06:32ZMutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro10.1038/s41598-017-03936-x2045-2322https://doaj.org/article/8ffed197854841b4b662d412e8d4c6922017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03936-xhttps://doaj.org/toc/2045-2322Abstract Activation-induced cytidine deaminase (AID) is known for its established role in antibody production. AID induces the diversification of antibodies by deaminating deoxycytidine (C) within immunoglobulin genes. The capacity of AID to deaminate 5-methyldeoxycytidine (5 mC) and/or 5-hydroxymethyldeoxycytidine (5 hmC), and consequently AID involvement in active DNA demethylation, is not fully resolved. For instance, structural determinants of AID activity on different substrates remain to be identified. To better understand the latter issue, we tested how mutations in human AID (hAID) influence its ability to deaminate C, 5 mC, and 5 hmC in vitro. We showed that each of the selected mutations differentially affects hAID’s ability to deaminate C and 5 mC. At the same time, we did not observe hAID activity on 5 hmC. Surprisingly, we found that the N51A hAID mutant, with no detectable activity on C, efficiently deaminated 5 mC, which may suggest different requirements for C and 5 mC deamination. Homology modeling and molecular dynamics simulations revealed that the pattern of enzyme-substrate recognition is one of the important factors determining enzyme activity on C and 5 mC. Consequently, we have proposed mechanisms that explain why wild type hAID more efficiently deaminates C than 5 mC in vitro and why 5 hmC is not deaminated.Lucyna BudzkoPaulina JackowiakKarol KamelJoanna SarzynskaJanusz M. BujnickiMarek FiglerowiczNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-16 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lucyna Budzko
Paulina Jackowiak
Karol Kamel
Joanna Sarzynska
Janusz M. Bujnicki
Marek Figlerowicz
Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro
description Abstract Activation-induced cytidine deaminase (AID) is known for its established role in antibody production. AID induces the diversification of antibodies by deaminating deoxycytidine (C) within immunoglobulin genes. The capacity of AID to deaminate 5-methyldeoxycytidine (5 mC) and/or 5-hydroxymethyldeoxycytidine (5 hmC), and consequently AID involvement in active DNA demethylation, is not fully resolved. For instance, structural determinants of AID activity on different substrates remain to be identified. To better understand the latter issue, we tested how mutations in human AID (hAID) influence its ability to deaminate C, 5 mC, and 5 hmC in vitro. We showed that each of the selected mutations differentially affects hAID’s ability to deaminate C and 5 mC. At the same time, we did not observe hAID activity on 5 hmC. Surprisingly, we found that the N51A hAID mutant, with no detectable activity on C, efficiently deaminated 5 mC, which may suggest different requirements for C and 5 mC deamination. Homology modeling and molecular dynamics simulations revealed that the pattern of enzyme-substrate recognition is one of the important factors determining enzyme activity on C and 5 mC. Consequently, we have proposed mechanisms that explain why wild type hAID more efficiently deaminates C than 5 mC in vitro and why 5 hmC is not deaminated.
format article
author Lucyna Budzko
Paulina Jackowiak
Karol Kamel
Joanna Sarzynska
Janusz M. Bujnicki
Marek Figlerowicz
author_facet Lucyna Budzko
Paulina Jackowiak
Karol Kamel
Joanna Sarzynska
Janusz M. Bujnicki
Marek Figlerowicz
author_sort Lucyna Budzko
title Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro
title_short Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro
title_full Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro
title_fullStr Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro
title_full_unstemmed Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro
title_sort mutations in human aid differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssdna substrates in vitro
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/8ffed197854841b4b662d412e8d4c692
work_keys_str_mv AT lucynabudzko mutationsinhumanaiddifferentiallyaffectitsabilitytodeaminatecytidineand5methylcytidineinssdnasubstratesinvitro
AT paulinajackowiak mutationsinhumanaiddifferentiallyaffectitsabilitytodeaminatecytidineand5methylcytidineinssdnasubstratesinvitro
AT karolkamel mutationsinhumanaiddifferentiallyaffectitsabilitytodeaminatecytidineand5methylcytidineinssdnasubstratesinvitro
AT joannasarzynska mutationsinhumanaiddifferentiallyaffectitsabilitytodeaminatecytidineand5methylcytidineinssdnasubstratesinvitro
AT januszmbujnicki mutationsinhumanaiddifferentiallyaffectitsabilitytodeaminatecytidineand5methylcytidineinssdnasubstratesinvitro
AT marekfiglerowicz mutationsinhumanaiddifferentiallyaffectitsabilitytodeaminatecytidineand5methylcytidineinssdnasubstratesinvitro
_version_ 1718384975057780736